Blood Lead Level Test Maker To Plead Guilty, Pay $42 Million for Concealing Devices’ Malfunctions

Dennis Tosh
May 22, 2024 at 08:50 PM EST
Image Image
A manufacturer of devices intended to test lead levels in blood has agreed to plead guilty to misbranding charges, pay $42 million, and enter into a deferred prosecution agreement resolving felony conspiracy charges in connection with the firm’s alleged multiyear concealment of widespread device malfunctions from the FDA and the company’s customers (United States v. Magellan D... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Related Articles